Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cheng, Zhe
NCT06341530: Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer	Recruiting	2	33	RoW	anlotinib combined with penpulimab, Anti-angiogenesis combined with immunotherapy	The First Affiliated Hospital of Zhengzhou University	Non-small Cell Lung Cancer	12/24	12/25
NCT05472324: Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.	Recruiting	2	220	RoW	TQC2731 injection, Placebo	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Severe Asthma	10/24	10/24